These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Influence of verapamil on some subcellular defects in diabetic cardiomyopathy. Afzal N; Pierce GN; Elimban V; Beamish RE; Dhalla NS Am J Physiol; 1989 Apr; 256(4 Pt 1):E453-8. PubMed ID: 2523196 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of diltiazem on the natural history of hypertensive diabetic cardiomyopathy in rats. Fein FS; Cho S; Malhotra A; Akella J; vanHoeven KH; Sonnenblick EH; Factor SM J Am Coll Cardiol; 1991 Nov; 18(5):1406-17. PubMed ID: 1833434 [TBL] [Abstract][Full Text] [Related]
5. Alterations in Ca(2+)-channels during the development of diabetic cardiomyopathy. Lee SL; Ostadalova I; Kolar F; Dhalla NS Mol Cell Biochem; 1992 Feb; 109(2):173-9. PubMed ID: 1320733 [TBL] [Abstract][Full Text] [Related]
7. Evidence against the involvement of nonenzymatic glycosylation in diabetic cardiomyopathy. Ganguly PK; Thliveris JA; Mehta A Metabolism; 1990 Jul; 39(7):769-73. PubMed ID: 2164131 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of chronic calcium channel blocker treatment on the inotropic response of diabetic rat myocardium to acute ethanol exposure. Brown RA; Sundareson AM; Lee MM; Savage AO Life Sci; 1996; 59(10):835-47. PubMed ID: 8761317 [TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of beraprost sodium, a stable prostacyclin analogue, in diabetic cardiomyopathy. Ueno Y; Koike H; Nishio S J Cardiovasc Pharmacol; 1995 Oct; 26(4):603-7. PubMed ID: 8569222 [TBL] [Abstract][Full Text] [Related]